1 active not recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
Follow Algernon Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Single and Repeat Doses of DMT in Healthy Subjects N,N-Dimethyltryptamine, Placebo - Stroke | Phase 1 | Active not recruiting | Algernon Pharmaceuticals | 60 | 2023-01-13 | 2025-01-28 |
Stroke (1)
Netherlands (1)